Inhibikase Therapeutics Collaboration AGREEMENT With Parkinson’s InstituteInhibikase Therapeutics Collaboration Agreement • October 16th, 2018 • Inhibikase Therapeutics, Inc. • Biological products, (no disgnostic substances)
This Company Sponsored Research Agreement (this “Agreement”), effective as of the date of the latest signature appearing on the signature page below (“Effective Date”), is by and between Parkinson’s Institute, with a principal place of business at 675 Almanor Avenue, Sunnyvale CA 94085 (“Institute”), and Inhibikase Therapeutics, Inc., with principal offices located at 3350 Riverwood Pkwy SE, Ste 1900, Atlanta, Georgia, 30339 (“Company”), and is subject to the terms and conditions set forth herein.
